Hepatitis C Combination Therapy - A Good AASLD Meeting Summary

A Good AASLD Meeting Summary
This is a terrific overview article regarding the AASLD meeting. Liz Highleyman did a fantastic job of condensing the key aspects and announcements. One of the most interesting updates/corrections of known information is the upward measurement of the number of...

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Viral Hepatitis
Title: Viral HepatitisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/5/2005